Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Max Bone-D
- Development stage
- Unknown
- Lead developer
- Ergon Pharmaceuticals
- Administration
- Oral
01
Overview
Max Bone-D is an Ayurvedic herbal supplement developed and manufactured by Ergon Pharmaceuticals in Bangladesh. It is primarily indicated for improving bone health and addressing calcium deficiency. The product's active ingredient is Manjistha (extracted from *Rubia cordifolia*), provided at a dosage of 500mg per capsule. It is marketed as a natural bone-strengthening agent that helps make bones stronger and healthier by addressing calcium-related issues. The supplement is produced following Good Manufacturing Practice (GMP) standards and is positioned as a side-effect-free herbal alternative for bone support.
- Brand names
- Max Bone-D
- Other names
- Max Bone-D Ayurvedic herbal calcium supplement
Beyond the preview
Go deeper on Max Bone-D.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Max Bone-D.